Cart
×
Ryan Getzlaf and Other Anaheim Ducks Teammates to Play in the 4th Annual Getzalf Golf Shootout to Benefit CureDuchenne on September 7
Newport Beach, Calif., SEPTEMBER 3, 2014 – Ryan Getzlaf, captain of the Anaheim Ducks, is hosting the fourth annual Getzlaf Golf Shootout to benefit CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy. This two-day charity golf event includes a reception at Sutra Lounge in Costa Mesa on September 6 and a golf tournament held at the Monarch Beach Golf Links in Dana Point on September 7. Each foursome will be teamed up with a professional athlete or celebrity for an exciting day on the green. Getzlaf will be joined by current and former Anaheim Ducks teammates:
|
|
|
“We are pleased to continue to support CureDuchenne and their efforts to find a cure for this devastating disease,” said Getzlaf. “Proceeds of this event will help fund research to find a cure for Duchenne. Join me and my wife, Paige, and help give boys with Duchenne a chance.”
Duchenne is a progressive muscle-wasting disease that impacts one in every 3,500 boys. Boys are usually diagnosed at age 5, are in a wheelchair by 12 and most don’t survive their mid-20s. Currently there is no cure for Duchenne.
Foursomes cost $2,800 and include an athlete or celebrity as a fifth golfer plus eight tickets to the pre-golf dinner reception. Meet and mingle with hockey players at the reception on September 6 at Sutra. There will be a live and silent auction. Individual tickets to the reception are $100. Go to www.CureDuchenne.org/GetzlafGolf to register. Sponsors include Patriot Environmental Services, CNC Motors, The Sports Corporation, Bauer Hockey, Taylor Made, Chino Valley Medical Center, Ayres Hotel, RESQWATER, Straub Distributing, Audi Mission Viejo and Flight Options.
For more information on CureDuchenne go to www.cureduchenne.org or call 949-872-2552. Follow us on Facebook, Twitter and YouTube.
About CureDuchenne
CureDuchenne is a national nonprofit organization located in Newport Beach, Calif., dedicated to finding a cure for Duchenne, the most common and most lethal form of muscular dystrophy. As the leading genetic killer of young boys, Duchenne affects more than 300,000 boys worldwide. CureDuchenne has garnered international attention for its efforts to raise funds and awareness for Duchenne. With the help of CureDuchenne’s distinguished international panel of Scientific Advisors, funds raised by CureDuchenne support the most promising research aimed at treating and curing Duchenne. To date, seven CureDuchenne research projects have made their way into human clinical trials – a unique accomplishment as few health-related nonprofits have been successful in being a catalyst for human clinical trials.
###
